|
(Health-NewsWire.Net, October 08, 2021 )
Market Overview
Female urinary incontinence has been diagnosed as a condition that causes involuntary urination. Urinary incontinence or stress urinary incontinence typically occurs during physical activities, such as sneezing, coughing, running, or even during weightlifting, as these activities exert pressure on the urinary bladder.
Urinary urge and stress incontinence are different, as the former occurs when the bladder muscles are contracted. Urinary stress incontinence affects women more than men and is mostly due to weak muscle sphincter, which can lead to social isolation.
Female urinary incontinence is of two types: the first is urethral hypermobility and the second is due to an inherent sphincter deficiency. In the case of urethra hypermobility, increased abdominal pressure changes the position of the urethra. On the other hand, in the inherent sphincter of the deficiency, the sphincter has lost its ability to seal the deficiency of the intestinal sphincter.
View full report: https://bit.ly/2YAcOp9
Market Dynamics
The major factors propelling the growth of the female urinary incontinence treatment device market are the rising prevalence of urinary incontinence in pregnant women, stress urinary incontinence due to diabetes, gynecology disorders, and urinary incontinence in postmenopausal women, and rising cases of hysterectomy. Moreover, the rising incidence of obesity in the female population is the major factor expected to deliver significant growth to the market in the upcoming period.
Rising prevalence of urinary incontinence in pregnant women
According to the National Center for Biotechnology Information, the prevalence of urinary incontinence during pregnancy in 750 was 300. (40 percent ). Stress urinary incontinence was the most common type of incontinence in pregnancy. 41.7 percent of nulliparous women, 38 percent of primipara women, and 20.3 percent of multi-parallel women experienced urinary incontinence.
Among women reporting UI, 29.3 percent experienced leakage a few times a day, and the amount of leakage was generally moderate (59.7 percent). Factors significantly associated with urinary incontinence included age group, gestational age, parity, prior urinary incontinence, constipation, last childbirth mode of delivery, previous urinary tract infection, body mass index during pregnancy.
Market Segmentation
By Product Type
• Urethral devices
• Internal vaginal devices
By Material used
• Polyurethane Foam
• Silicone
By End user
• Hospitals
• Specialty clinics
• Ambulatory surgical centers
Download free sample: https://bit.ly/3FrLDNV
Geographical Analysis
Based on geography, the study analyzes the female urinary incontinence treatment device market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
North America is expected to dominate the global female urinary incontinence treatment device market.
North America is held a dominant position in the global female urinary incontinence treatment device market in 2019. In North America, the U.S. is expected to represent considerable growth during the forecast period. In the U.S., the female urinary incontinence treatment device is expected to have potential growth due to the rising prevalence of urinary incontinence in pregnant women, and stress urinary incontinence due to diabetes, gynecology disorders, and urinary incontinence in postmenopausal women.
The Asia-Pacific market is projected to expand significantly during the forecast period due to increased awareness, increased investment in health care to provide optimum facilities at affordable cost, and socio-economic development.
The increase in the number of women smoking in China is expected to boost the market. Increased investment by prominent players in developing countries is expected to boost the market. The Middle East & Africa market is projected to expand at a slow pace due to lack of awareness, low disposable income, and limited healthcare facilities.
Competitive Landscape
The key female urinary incontinence treatment device market players which are contributing to the growth of the global market include are Karl Storz, Johnson & Johnson, Coloplast, Boston Scientific, Teleflex, American Medical Solutions, among others. The major players are adopting new product launch and expansion strategies for global growth in the female urinary incontinence treatment device market.
Related Topic's
Monopolar Electrosurgical Instruments Market, Advanced Vessel Sealing Instruments Market, Appendicitis Diagnostics and Treatment Market, Gynecological Devices Market, Interventional Oncology Devices Market
DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com
Source: EmailWire.Com 
|
